Jul 1 |
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
|
Jun 18 |
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
Jun 3 |
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
|
May 15 |
Kintara Therapeutics GAAP EPS of -$0.05
|
May 14 |
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 4 |
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
|
Apr 3 |
Kintara to merge with TuHURA Bio in all-stock deal
|
Apr 3 |
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
|
Mar 28 |
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
|